PBT2 in Huntington Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
机构：
来源：
ANNALS OF NEUROLOGY | 2014年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S451 WIP
引用
收藏
页码：S51 / S52
页数：2
相关论文
共 50 条
  • [41] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [42] Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
    Stephen A. Harrison
    Peter J. Ruane
    Bradley L. Freilich
    Guy Neff
    Rashmee Patil
    Cynthia A. Behling
    Chen Hu
    Erica Fong
    Brittany de Temple
    Erik J. Tillman
    Timothy P. Rolph
    Andrew Cheng
    Kitty Yale
    Nature Medicine, 2021, 27 : 1262 - 1271
  • [43] Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
    Harrison, Stephen A.
    Ruane, Peter J.
    Freilich, Bradley L.
    Neff, Guy
    Patil, Rashmee
    Behling, Cynthia A.
    Hu, Chen
    Fong, Erica
    de Temple, Brittany
    Tillman, Erik J.
    Rolph, Timothy P.
    Cheng, Andrew
    Yale, Kitty
    NATURE MEDICINE, 2021, 27 (07) : 1262 - +
  • [44] Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
    Stephen A. Harrison
    Rebecca Taub
    Guy W. Neff
    K. Jean Lucas
    Dominic Labriola
    Sam E. Moussa
    Naim Alkhouri
    Mustafa R. Bashir
    Nature Medicine, 2023, 29 : 2919 - 2928
  • [45] A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    Kondo, Tomoyoshi
    Nomoto, Masahiro
    Origasa, Hideki
    Takahashi, Ryosuke
    Yamamoto, Mitsutoshi
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 201 - 207
  • [46] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
    Leber, Andrew
    Hontecillas, Raquel
    Juni, Nuria Tubau
    Bassaganya-Riera, Josep
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S821 - S821
  • [47] PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism
    Khan, Aliya A.
    Rejnmark, Lars
    Rubin, Mishaela
    Schwarz, Peter
    Vokes, Tamara
    Clarke, Bart
    Ahmed, Intekhab
    Hofbauer, Lorenz
    Marcocci, Claudio
    Pagotto, Uberto
    Palermo, Andrea
    Eriksen, Erik
    Brod, Meryl
    Markova, Denka
    Smith, Alden
    Pihl, Susanne
    Mourya, Sanchita
    Karpf, David B.
    Shu, Aimee D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (01): : E372 - E385
  • [48] A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of Telitacicept in Patients with IgA Nephropathy and Persistent Proteinuria
    Lv, Jicheng
    Liu, Lijun
    Hao, Chuan-Ming
    Li, Guisen
    Fu, Ping
    Xing, Guangqun
    Zheng, Hongguang
    Chen, Nan
    Caili, Wang
    Luo, Ping
    Qiong, Xie D.
    Zuo, Li
    Wang, Yue
    Li, Rongshan
    Mao, Yonghui
    Dong Shaoshao
    Zhang, Pengfei
    Zheng, Hui X.
    Wang, Wenxiang
    Li, Lin
    Jiao, Wenjuan
    Fang, Jianmin
    Zhang, Hong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B10 - B10
  • [49] Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
    Harrison, Stephen A.
    Taub, Rebecca
    Neff, Guy W.
    Lucas, K. Jean
    Labriola, Dominic
    Moussa, Sam E.
    Alkhouri, Naim
    Bashir, Mustafa R.
    NATURE MEDICINE, 2023, 29 (11) : 2919 - 2928
  • [50] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    V. Ratziu
    L. de Guevara
    R. Safadi
    F. Poordad
    F. Fuster
    J. Flores-Figueroa
    M. Arrese
    Anna L. Fracanzani
    D. Ben Bashat
    K. Lackner
    T. Gorfine
    S. Kadosh
    R. Oren
    M. Halperin
    L. Hayardeny
    R. Loomba
    S. Friedman
    Arun J. Sanyal
    Nature Medicine, 2021, 27 : 1825 - 1835
12345